Lactulose
Lactulose is a pharmaceutical drug with 66 clinical trials. Currently 3 active trials ongoing. Historical success rate of 88.2%.
Success Metrics
Based on 30 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
12
Mid Stage
25
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.9%
30 of 39 finished
23.1%
9 ended early
3
trials recruiting
66
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Prospective, Multicenter, Randomized, Parallel-controlled, Superiority Trial
Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy
UDCA to Prevent Post-TIPS Hepatic Encephalopathy
LiveSMART Trial to Prevent Falls in Patients With Cirrhosis
Efficacy and Safety of Nifuroxazide in the Treatment of Hepatic Encephalopathy in Egyptian Patients With Liver Cirrhosis
Clinical Trials (66)
A Prospective, Multicenter, Randomized, Parallel-controlled, Superiority Trial
Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy
UDCA to Prevent Post-TIPS Hepatic Encephalopathy
LiveSMART Trial to Prevent Falls in Patients With Cirrhosis
Efficacy and Safety of Nifuroxazide in the Treatment of Hepatic Encephalopathy in Egyptian Patients With Liver Cirrhosis
Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)
Combination of Lactulose and Polyethylene Glycol Electrolytes Powder (PEG-ELS) for Bowel Preparation in Type II Diabetes Mellitus Patients
A Trial for Comparing Rifaximin, Probiotic and L-ornithine- L Aspartate With Lactulose in Overt Hepatic Encephalopathy.
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE
Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF)
Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis.
Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis
Goal Directed Ammonia Lowering Therapy in Hyperammonemic ACLF Patients With no Overt HE to Reduce Major Adverse Liver Related Outcomes (GOAL Trial)
Clinical Study on the Application of Lactulose Combined with Linaclotide in Bowel Preparation for Colonoscopy
Lactulose vs. Polyethylene Glycol as Bowel Preparation for Colonoscopy in Adults
A Trial to Improve Quality of Life in People With Cirrhosis
Assesment of Lactulose vs Lactobacillus Acidophilus Effect in CKD Patients
Polyethylene Glycol Versus Lactulose on Hepatic Encephalopathy in Patients With Cirrhosis;(PEGHE Trial)
Effectiveness of Oral Lactulose Versus Lactulose Enema in Hepatic Encephalopathy
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 66